Search

everythinglearnresearchcommunity

for

Search:↓

A young Saudi girl with uncontrolled type 1 diabetes and hypothyroidism had two rare conditions, Mauriac syndrome and Van Wyk–Grumbach syndrome.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Researchers found a genetic link for hereditary hair loss but need more analysis to identify the exact gene.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.